Karen Aleman

1.9k total citations
38 papers, 1.3k citations indexed

About

Karen Aleman is a scholar working on Oncology, Pathology and Forensic Medicine and Infectious Diseases. According to data from OpenAlex, Karen Aleman has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 15 papers in Pathology and Forensic Medicine and 8 papers in Infectious Diseases. Recurrent topics in Karen Aleman's work include Viral-associated cancers and disorders (27 papers), Lymphoma Diagnosis and Treatment (14 papers) and Histiocytic Disorders and Treatments (8 papers). Karen Aleman is often cited by papers focused on Viral-associated cancers and disorders (27 papers), Lymphoma Diagnosis and Treatment (14 papers) and Histiocytic Disorders and Treatments (8 papers). Karen Aleman collaborates with scholars based in United States, South Africa and India. Karen Aleman's co-authors include Robert Yarchoan, Richard F. Little, Kathleen M. Wyvill, Denise Whitby, Vickie Marshall, Seth M. Steinberg, Thomas S. Uldrick, Stefania Pittaluga, Mark N. Polizzotto and Deirdre O’Mahony and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Karen Aleman

38 papers receiving 1.2k citations

Peers

Karen Aleman
KS Anderson United States
Bal Kampalath United States
K Flynn United States
Bruce A. Robbins United States
Carol Holman United States
Ashita Waterston United Kingdom
KS Anderson United States
Karen Aleman
Citations per year, relative to Karen Aleman Karen Aleman (= 1×) peers KS Anderson

Countries citing papers authored by Karen Aleman

Since Specialization
Citations

This map shows the geographic impact of Karen Aleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Aleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Aleman more than expected).

Fields of papers citing papers by Karen Aleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Aleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Aleman. The network helps show where Karen Aleman may publish in the future.

Co-authorship network of co-authors of Karen Aleman

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Aleman. A scholar is included among the top collaborators of Karen Aleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Aleman. Karen Aleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lurain, Kathryn, Mark N. Polizzotto, Karen Aleman, et al.. (2019). Viral, immunologic, and clinical features of primary effusion lymphoma. Blood. 133(16). 1753–1761. 83 indexed citations
2.
Polizzotto, Mark N., Thomas S. Uldrick, Kathleen M. Wyvill, et al.. (2016). Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study. Journal of Clinical Oncology. 34(34). 4125–4131. 86 indexed citations
3.
Polizzotto, Mark N., Thomas S. Uldrick, Kathleen M. Wyvill, et al.. (2015). Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS). Clinical Infectious Diseases. 62(6). 730–738. 141 indexed citations
4.
Polizzotto, Mark N., Corina Millo, Thomas S. Uldrick, et al.. (2015). 18 F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus–Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters. The Journal of Infectious Diseases. 212(8). 1250–1260. 25 indexed citations
5.
Uldrick, Thomas S., Mark N. Polizzotto, Karen Aleman, et al.. (2014). Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease. Blood. 124(24). 3544–3552. 80 indexed citations
6.
Peer, Cody J., Mark N. Polizzotto, Thomas S. Uldrick, et al.. (2014). A sensitive and robust HPLC assay with fluorescence detection for the quantification of pomalidomide in human plasma for pharmacokinetic analyses. Journal of Pharmaceutical and Biomedical Analysis. 92. 63–68. 22 indexed citations
7.
Polizzotto, Mark N., Thomas S. Uldrick, Rafa Rahman, et al.. (2013). Evaluation of Non-Invasive Multispectral Imaging as a Tool for Measuring the Effect of Systemic Therapy in Kaposi Sarcoma. PLoS ONE. 8(12). e83887–e83887. 4 indexed citations
8.
Venkataraman, Girish, Thomas S. Uldrick, Karen Aleman, et al.. (2013). Bone Marrow Findings in HIV-Positive Patients With Kaposi Sarcoma Herpesvirus–Associated Multicentric Castleman Disease. American Journal of Clinical Pathology. 139(5). 651–661. 22 indexed citations
9.
Polizzotto, Mark N., Thomas S. Uldrick, Victoria Wang, et al.. (2013). Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Blood. 122(26). 4189–4198. 115 indexed citations
10.
Ray, Alex, Vickie Marshall, Thomas S. Uldrick, et al.. (2012). Sequence Analysis of Kaposi Sarcoma–Associated Herpesvirus (KSHV) MicroRNAs in Patients with Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome. The Journal of Infectious Diseases. 205(11). 1665–1676. 31 indexed citations
12.
Yu, Huifeng, Amiran Dzutsev, Marianna Sabatino, et al.. (2011). IL-15 ex vivo overcomes CD4+ T cell deficiency for the induction of human antigen-specific CD8+ T cell responses. Journal of Leukocyte Biology. 90(1). 205–214. 11 indexed citations
13.
Valentin, Antonio, et al.. (2010). Identification of a Potential Pharmacological Sanctuary for HIV Type 1 in a Fraction of CD4 + Primary Cells. AIDS Research and Human Retroviruses. 26(1). 79–88. 7 indexed citations
14.
Uldrick, Thomas S., Victoria Wang, Deirdre O’Mahony, et al.. (2010). An Interleukin‐6–Related Systemic Inflammatory Syndrome in Patients Co‐Infected with Kaposi Sarcoma–Associated Herpesvirus and HIV but without Multicentric Castleman Disease. Clinical Infectious Diseases. 51(3). 350–358. 215 indexed citations
15.
Yarchoan, Robert, James M. Pluda, Kathleen M. Wyvill, et al.. (2007). PART IV. Cytokine and Hormone ImmunotherapyTreatment of AIDS-Related Kaposi's Sarcoma with Interleukin-12: Rationale and Preliminary Evidence of Clinical Activity. Critical Reviews in Immunology. 27(5). 401–414. 26 indexed citations
16.
Marshall, Vickie, Rachel Bagni, Mark A. Samols, et al.. (2007). Conservation of Virally Encoded MicroRNAs in Kaposi Sarcoma–Associated Herpesvirus in Primary Effusion Lymphoma Cell Lines and in Patients with Kaposi Sarcoma or Multicentric Castleman Disease. The Journal of Infectious Diseases. 195(5). 645–659. 80 indexed citations
17.
O’Mahony, Deirdre, Karen Aleman, Denise Whitby, et al.. (2007). Early Results of a Clinical Trial Using Targeted Oncolytic Virotherapy in Kaposi Sarcoma Herpes Virus (KSHV) Associated Multicentric Castleman’s Disease (MCD).. Blood. 110(11). 514–514. 1 indexed citations
18.
Dasgeb, Bahar, Moinuddin Hassan, Franck Amyot, et al.. (2006). Using Quantitative Imaging Techniques to Assess Vascularity in AIDS-Related Kaposi's Sarcoma. PubMed. 3. 232–235. 6 indexed citations
19.
Gandjbakhche, Amir, Franck Amyot, Victor Chernomordik, et al.. (2005). Noninvasive Multimodality Imaging Techniques to Assess Kaposi's Sarcoma. PubMed. 34. 694–696. 1 indexed citations
20.
Hassan, Moinuddin, Stavros G. Demos, Karen Aleman, et al.. (2005). Noninvasive infrared imaging for quantitative assessment of tumor vasculature and response to therapy. PubMed. 3. 1200–1202. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026